In view of increasing demand for AYUSH products and services by people amid Covid-19 pandemic, the Indian Medicines Pharmaceutical Corporation Limited (IMPCL), a public sector manufacturing unit of the Union Ministry of AYUSH, has recorded its highest-ever turnover of Rs 164 crore in 2020-21.
The company has recorded an all-time high profit of approximately Rs 12 crore, the Union AYUSH Ministry said in a statement here on Tuesday.
Its previous highest turnover was Rs 97 crore in 2019-20.
Adding another feather in IMPCL’’s cap, the Central Drugs Standard Control Organisation recommended its 18 Ayurvedic products for WHO-GMP/COPP certification subject to certain observations in March 2021.
The WHO provides ‘’World Health Organization, Good Manufacturing Practices / Certificate of Pharmaceutical Product (WHO-GMP/CoPP)’’ certification to companies after conducting an inspection.
This certification is an endorsement of the quality of IMPCL’’s products. It will help IMPCL to commence export of quality medicines.
IMPCL is one of the most trusted manufacturers of AYUSH medicines in the country and is known for the authenticity of its formulations.
“During the COVID-19 pandemic, it was able to cater to the needs of the country in the shortest time, probably the first company in the country to provide Immuno boosting medicines as AurakshaImmuno Boosting Kit.